Risk Stratification as a Predictive Factor for Cephalosporin Allergy: A Case-Controlled Study

Area of Science:

• Pediatric Allergy and Immunology
• Clinical Microbiology
• Drug Hypersensitivity

Background:

• Cephalosporin allergies are less common but less standardized to diagnose in children compared to penicillin allergies.
• A European Academy of Allergy and Clinical Immunology position paper proposed a risk stratification system for suspected beta-lactam hypersensitivity reactions.

Purpose of the Study:

• To evaluate the effectiveness of risk stratification in predicting confirmed cephalosporin hypersensitivity.
• To identify predictive factors for confirmed cephalosporin hypersensitivity in pediatric patients.

Main Methods:

• A case-controlled study involving patients with confirmed cephalosporin hypersensitivity (skin tests and drug provocation).
• Age- and gender-matched control subjects were included.
• Retrospective analysis of patient records with risk stratification based on reaction severity (high/low risk) and timing (immediate/delayed).

Main Results:

• Immediate and high-risk reactions were significantly associated with confirmed cephalosporin hypersensitivity (Odds Ratio [OR] > 5, p < 0.001).
• Multivariate analysis confirmed immediate (OR: 7.5) and high-risk (OR: 5.2) reactions as significant predictors.
• Risk stratification showed distinct distributions between patient and control groups for immediate/delayed and high/low-risk reactions.

Conclusions:

• The developed risk stratification model is applicable to children with suspected cephalosporin allergy.
• Skin testing is valuable for high-risk, immediate reaction patients, potentially reducing drug provocation testing.
• Provocation tests may directly diagnose low-risk patients, while high-risk and immediate reactions predict confirmed allergy.